GeneDx Holdings (WGS) Income towards Parent Company (2020 - 2025)
Historic Income towards Parent Company for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$7.6 million.
- GeneDx Holdings' Income towards Parent Company rose 814.49% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10249.55%. This contributed to the annual value of -$52.3 million for FY2024, which is 7025.27% up from last year.
- GeneDx Holdings' Income towards Parent Company amounted to -$7.6 million in Q3 2025, which was up 814.49% from $10.8 million recorded in Q2 2025.
- GeneDx Holdings' Income towards Parent Company's 5-year high stood at $32.7 million during Q3 2021, with a 5-year trough of -$308.7 million in Q4 2022.
- For the 5-year period, GeneDx Holdings' Income towards Parent Company averaged around -$54.0 million, with its median value being -$40.2 million (2021).
- As far as peak fluctuations go, GeneDx Holdings' Income towards Parent Company soared by 15781.33% in 2021, and later plummeted by 66822.94% in 2022.
- GeneDx Holdings' Income towards Parent Company (Quarter) stood at -$40.2 million in 2021, then crashed by 668.23% to -$308.7 million in 2022, then skyrocketed by 91.65% to -$25.8 million in 2023, then skyrocketed by 121.1% to $5.4 million in 2024, then plummeted by 240.4% to -$7.6 million in 2025.
- Its Income towards Parent Company was -$7.6 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$6.5 million in Q1 2025.